These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22355051)

  • 1. Targeted immunotherapy for hairy cell leukemia.
    Park JH; Levine RL
    J Clin Oncol; 2012 May; 30(15):1888-90. PubMed ID: 22355051
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials referral resource.
    Cheson BD
    Oncology (Williston Park); 1990 Nov; 4(11):72. PubMed ID: 2150327
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy and immunotherapy in metastatic colorectal cancer.
    Frati L; Codacci-Pisanelli G
    N Engl J Med; 2009 May; 360(20):2134-5; author reply 2135-6. PubMed ID: 19445031
    [No Abstract]   [Full Text] [Related]  

  • 4. Integration of targeted therapies with cytotoxic chemotherapy in the treatment of colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2010 Jun; 9 Suppl 1():S6. PubMed ID: 20630852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy and immunotherapy in metastatic colorectal cancer.
    Copur MS; Norvell M; Obermiller A
    N Engl J Med; 2009 May; 360(20):2135; author reply 2135-6. PubMed ID: 19445033
    [No Abstract]   [Full Text] [Related]  

  • 7. [First-line chemotherapy for unresectable and metastatic colorectal cancer].
    Satoh T
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1372-5. PubMed ID: 25577805
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintenance therapy in metastatic colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):388-90. PubMed ID: 25003569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adjuvant and palliative therapy for colorectal carcinoma].
    Heike M; Wölfel T; Meyer zum Büschenfelde KH; Knuth A; Dippold WG
    Dtsch Med Wochenschr; 1994 May; 119(21):778-85. PubMed ID: 7514969
    [No Abstract]   [Full Text] [Related]  

  • 10. Explaining the unexplainable: EGFR antibodies in colorectal cancer.
    Grothey A; Lenz HJ
    J Clin Oncol; 2012 May; 30(15):1735-7. PubMed ID: 22473160
    [No Abstract]   [Full Text] [Related]  

  • 11. [Regional adjuvant chemotherapy in colorectal cancer].
    Shparyk IaV; Bilyns'kyĭ BT
    Klin Khir; 1995; (9-10):41-5. PubMed ID: 8697216
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy and immunotherapy in metastatic colorectal cancer.
    Pohlmann PR; Mernaugh RL; Goff LW
    N Engl J Med; 2009 May; 360(20):2134; author reply 2135-6. PubMed ID: 19439750
    [No Abstract]   [Full Text] [Related]  

  • 13. Another effective chemotherapy combination for colorectal cancer.
    Oncology (Williston Park); 1988 Nov; 2(11):68. PubMed ID: 3275045
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimum chemotherapy for metastatic colorectal cancer.
    Bendell J
    Lancet; 2006 Dec; 368(9552):2039-41. PubMed ID: 17161715
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual blockade of epidermal growth factor receptor-induced pathways: a new avenue to treat metastatic colorectal cancer.
    Laurent-Puig P; Manceau G; Zucman-Rossi J; Blons H
    J Clin Oncol; 2012 May; 30(13):1550-2. PubMed ID: 22412137
    [No Abstract]   [Full Text]